drugset / Trial / NCT06094790
A Study to Evaluate the Pharmacokinetics of the Current Capsule Formulation of CORT125134 in Healthy Subjects
RandomizedParallel-groupOpen-labelOther
Summary
A study designed to characterize the plasma pharmacokinetic (PK) profile of CORT125134 in healthy subjects receiving once-daily oral administration of the current capsule formulation of CORT125134 for 14 days.
Timeline
- Start
- 2017-05-18
- Primary completion
- 2017-11-15
- Completion
- 2017-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Relacorilant | Small molecule | 150 mg | Oral |
| Subject | Relacorilant | Small molecule | 250 mg | Oral |
Indications
No indication recorded.